In agreement with these results, analysis of survival rates, with endpoint based on the time that animals needed to be killed because of the tumor size, showed improved survival in the anti-PD-1-treated group vs. the corresponding vehicle-treated controls (Fig. 6b). This evidence concerns the gene PDCD1 and neoplasm.